Compounds > anidulafungin
Page last updated: 2024-09-05

anidulafungin and Pneumonia, Pneumocystis

anidulafungin has been researched along with Pneumonia, Pneumocystis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ashbaugh, A; Cushion, MT; Hauser, PM; Mosley, C; Sayson, SG1
Adeojo, LW; Alfaro, R; Ashbaugh, A; Cushion, MT; Kovacs, JA; Kumar, P; Lu, R; Mannino, R; Tramont, E1
Ashbaugh, A; Cushion, MT; Hendrix, K; Linke, MJ; Porollo, A; Sayson, SG; Tisdale, N1
Damiani, C; Le Gal, S; Nevez, G; Totet, A1
Chang, HC; Chen, TC; Yang, WT1
Ashbaugh, A; Collins, MS; Cushion, MT; Linke, MJ; Lynch, K1
Bartlett, MS; Boylan, CJ; Current, WL; Goheen, MP; Lee, CH; Queener, SF; Shaw, MM; Smith, JW1

Other Studies

7 other study(ies) available for anidulafungin and Pneumonia, Pneumocystis

ArticleYear
Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication.
    Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6

    Topics: Anidulafungin; Animals; Echinocandins; Ecosystem; Pneumocystis; Pneumonia, Pneumocystis

2022
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia.
    The Journal of infectious diseases, 2021, 07-15, Volume: 224, Issue:2

    Topics: Anidulafungin; Animals; Antifungal Agents; Atovaquone; Disease Models, Animal; Mice; Pneumonia, Pneumocystis

2021
Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Male; Mice; Pneumocystis; Pneumonia, Pneumocystis

2018
The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Anidulafungin; Animals; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Echinocandins; Mice; Pneumocystis; Pneumocystis carinii; Pneumonia, Pneumocystis

2018
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:24

    Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Antiretroviral Therapy, Highly Active; Glucosephosphate Dehydrogenase Deficiency; HIV Infections; Humans; Immunocompromised Host; Male; Pneumonia, Pneumocystis; Treatment Outcome; Young Adult

2018
Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.
    Infection and immunity, 2013, Volume: 81, Issue:3

    Topics: Albumins; Anidulafungin; Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cell Wall; Echinocandins; Female; Flow Cytometry; Inflammation; Lung; Mice; Mice, Inbred C3H; Pneumocystis; Pneumonia, Pneumocystis

2013
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:8

    Topics: Anidulafungin; Animals; Antifungal Agents; Cell Line; Cell Wall; Dexamethasone; Echinocandins; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Rats

1996